Delivery Order SPE2DB25D3306-SPE2DB25FUCRE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,881.75 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $2,089.66. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Viberzi 75 mg tablets (60-count units) with a ceiling value of $2,002.01. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of VIBERZI 75 mg tablets (60-count units) valued at $3,019.24. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award. The contract is set to be completed by August 12, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. VIBERZI (vibegron) is a prescription medication used...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100mg, with a ceiling value of $2,276.80. This competitive award, effective August 12, 2025, with an ultimate completion date of August 13, 2025, was executed under firm fixed-price terms with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $1,852.16. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is classified as a child order under the parent SPE2DX IDC, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $3,689.52 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Viberzi 75 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of VIBERZI 100 MG tablets (60-count units) valued at $1,138.42 under a firm fixed-price contract. This award, which carries an ultimate completion date of August 8, 2025, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,707.63 firm fixed price contract is for the delivery of Viberzi 100 mg Tablets in quantities of 60. The contract has a performance period ending on May 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which allows the company to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,707.63 for 60 tablets of Viberzi 100 mg, with a completion date of July 28, 2025. This competitively awarded, firm fixed-price contract represents a pediatric order from the pharmaceutical distributor's extensive portfolio of federal medical supply contracts. The contract was executed on July 25, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCREDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,329.50 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, and performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. Viberzi (vibegron) is a beta-3 adrenergic agonist used in the treatment of overactive bladder. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The company's comprehensive DLA contract vehicle enables the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/18/25 |